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hippocampal gene expression in BALB/cJ and
C57BL/6J mouse strains
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Irfan Jumabhoy1, Frans Sluyter1, Wim E Crusio4,7 and Leonard C Schalkwyk6
Abstract
Background: BALB/cJ is a strain susceptible to stress and extremely susceptible to a defective hedonic impact in
response to chronic stressors. The strain offers much promise as an animal model for the study of stress related
disorders. We present a comparative hippocampal gene expression study on the effects of unpredictable chronic mild
stress on BALB/cJ and C57BL/6J mice. Affymetrix MOE 430 was used to measure hippocampal gene expression from
16 animals of two different strains (BALB/cJ and C57BL/6J) of both sexes and subjected to either unpredictable
chronic mild stress (UCMS) or no stress. Differences were statistically evaluated through supervised and unsupervised
linear modelling and using Weighted Gene Coexpression Network Analysis (WGCNA). In order to gain further
understanding into mechanisms related to stress response, we cross-validated our results with a parallel study from
the GENDEP project using WGCNA in a meta-analysis design.
Results: The effects of UCMS are visible through Principal Component Analysis which highlights the stress sensitivity
of the BALB/cJ strain. A number of genes and gene networks related to stress response were uncovered including the
Creb1 gene. WGCNA and pathway analysis revealed a gene network centered on Nfkb1. Results from the meta-analysis
revealed a highly significant gene pathway centred on the Ubiquitin C (Ubc) gene. All pathways uncovered are
associated with inflammation and immune response.
Conclusions: The study investigated the molecular mechanisms underlying the response to adverse environment in
an animal model using a GxE design. Stress-related differences were visible at the genomic level through PCA analysis
highlighting the high sensitivity of BALB/cJ animals to environmental stressors. Several candidate genes and gene
networks reported are associated with inflammation and neurogenesis and could serve to inform candidate gene
selection in human studies and provide additional insight into the pathology of Major Depressive Disorder.
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Background
Major depressive disorder (MDD), characterised by a core
of low mood, anhedonia and fatigability, has a lifetime
prevalence of 15–20% and is associated with significant
morbidity and mortality, particularly from a range of
chronic health conditions [1-3]. Research into this com-
plex disorder has traditionally used animal models, which
are broadly grouped as either tests of antidepressant
action (e.g. forced swim test) or models of depression-
like behaviors (e.g. chronic social defeat). The advantages
of using animal models including the ability to control
for environmental factors and the access to post-mortem
brain tissue are balanced by inherent limitations, most
notably the inability to convincingly replicate several
symptoms (e.g. suicidal ideation and delusions) involved
in the clinical diagnosis of MDD [4]. In addition, given our
lack of understanding of causative agents inMDD, and the
multitude of possible factors, the majority of these models
lack aetiological validity.
This is overcome, in part, by the use of stressor-based
models as exposure to stressful life events has previously
been implicated in MDD [5-9]. Unpredictable chronic
mild stress (UCMS) involves subjecting rodents to a series
of repeated physical stressors (e.g. food and water depri-
vation, cage tilting, social isolation etc.) for a prolonged
period of time (usually over 2 weeks) [10-12]. This results
in the development of anhedonic features (e.g. reduced
sucrose intake) that are sensitive to chronic, but not acute
administration of antidepressants, and thus more closely
resembles the chronic, multidimensional nature of clini-
cal MDD [13,14]. The validity, reliability and limitations
of UCMS protocols have been discussed extensively [15].
The value of such a mouse model is further enhanced
by the use of inbred mice strains, which allow the pro-
duction of multiple progeny with stable and identical
genetic material, but with differing phenotypic character-
istics. For instance, it has been shown that inbred strains
of mice present different thresholds of susceptibility to
UCMS [16-19].
Two commonly used strains are C57BL/6J and BALB/cJ,
which differ in several regards. Principally, BALB/cJ
appears to exhibit markedly elevated levels of anxi-
ety and stress reactivity, compared with the relatively
nonanxious C57BL/6J strain, across several different
approach/avoidance paradigms [20-25]. These mice also
display altered stress-related behaviours such as stretch-
attend postures, defecation, and licking/grooming, with a
corresponding increase in activation of the hypothalamic-
pituitary-adrenal (HPA) axis - a regulator of the stress
response [26-29]. Conversely, studies have indicated
that C57BL/6J mice demonstrate greater depression-like
behaviour in several paradigms, including the forced
swim test [30-33]. Furthermore, BALB/cJ, but not
C57BL/6J mice, were found to be sensitive to chronic,
but not sub-chronic/daily, antidepressant administration
[21,34].
The behavioural variation found between strains of
inbred mice represent potentially valuable information
on the molecular mechanisms underlying MDD, and can
be investigated using gene expression profiling across
strains [35]. Of particular interest is the hippocampal
brain region; a main target for the action of glucocorticoid
stress hormones which underlie cognitive performance,
behavioural adaptation and regulation of the HPA-axis.
Further, direct regulation of cholinergic signaling in this
brain area can induce depression-like phenotypes and is
also critical for antidepressant efficacy [36,37]. In MDD,
chronic administration of different classes of antidepres-
sants increases the proliferation, as well as the number,
of newly formed neurones in this area, an effect not seen
with non-antidepressant psychotropic medications [38].
In the present experiment we assessed hippocampal
gene expression profiles across two inbred strains of
mice subjected to either UCMS or no treatment in
order to examine the potential effects of UCMS on gene
expression.
Methods
Design
We explored mRNA expression differences in response to
Unpredictable Chronic Mild Stress (UCMS) in two inbred
mouse strains (BALB/cJ and C57BL/6J). An equal num-
ber of male and female mice from each strain were used
in a balanced design. Half the animals from each strain
were assigned to the UCMS group and the other half to a
Control group. The study consisted of 2 strains (BALB/cJ,
C57BL/6J), 2 two sexes (Male and Female), and two stress
conditions (UCMS, Control) for a total of 8 experimental
cells. In order to gain further insight into the molecu-
lar mechanisms that may play a role in stress response,
we cross-validated gene modules associated with stress
response with a parallel study from the GENDEP project.
This was done using WGCNA (Weighted Gene Co-
Expression Network analysis) in a meta-analysis design. A
detailed description of the GENDEPmouse study is found
elsewhere [39,40]). Briefly, the GENDEP study design con-
sisted of 4 inbred mouse strains (129S1/SvlmJ, C57LB/6J,
DBA/2J and FVB/NJ) exposed to two depressogenic pro-
tocols (Unpredictable Chronic Mild Stress and Maternal
Separation) and a Control condition.
Animals
Breeders were purchased from The Jackson Laboratory
(Bar Harbor, ME, USA) and bred at the animal facility at
UMass Medical School, Worcester, for at least two gener-
ations. Weaning took place at 28 ±1 days and mice from
3 to 7 different litters per strain and treatment condition
were housed in same sex groups of 2 to 4 litter mates until
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they reached the age of 2 months ±1 week. At this age,
animals were ear-punched for identification and assigned
to one of two treatment groups, controls and UCMS. The
UCMS treatment started at the same time and continued
during the behavioural testing phase. However, care was
taken not to apply stressors just before a test. The tests
took place 7 weeks after the beginning of the stress proce-
dure. Due to the nature of the UCMS procedure, stressed
and control animals were kept in separate but otherwise
identical holding rooms. Breeding, UCMS protocol and
micro-dissections were done on-site at the University of
Massachusetts. RNA extraction from frozen hippocampi
samples and microarray analysis was performed at the
MRC SGDP center, at the Institute of Psychiatry, London.
Animals from the GENDEP study used for the WGCNA
meta-analysis have been described in more detail else-
where [41-43]. All housing and experimental procedures
for the GENDEP study were carried out in accordance
with the UKHome Office Animals (Scientific Procedures)
Act, 1986.
Unpredictable Chronic Mild Stress UCMS
The UCMS model is based on repeated and inescapable
stressors that eventually lead to depression-like pheno-
types in mice. This approach stems from previous studies
showing that stress and major life events are critical risks
factors formajor depressive disorders [44].Mice were sub-
jected to different kinds of stressors such as: cage tilting,
damp sawdust, predator sounds, placement in an empty
cage, placement in an empty cage with water on the bot-
tom, inversion of the light/dark cycle, lights on for a short
period of time during the dark phase, and switching cages
following previously published protocols [41,45]. On aver-
age, two of these stressors were applied daily following
a semi-random two-week schedule. The stress procedure
lasted for 4 weeks prior to the behavioural testing. Stres-
sors continued to be applied during the testing phase,
except on testing days to avoid effects of acute stress. At
least 12 hours of rest was provided between a stressor and
a test. The stress procedure did not include any food or
water deprivation.
mRNA extraction
Total RNAwas extracted using the guanidium thiocyanate
method with TRIzol (Invitrogen Life Technologies, UK)
from 16 hippocampi (RNA preparation); (2) mRNA con-
verted to cDNA using reverse transcriptase and poly-T
primer; (3) Resulting cDNA was amplified using T7 RNA
polymerase in the presence of biotin-UTP and biotin-
CTP, so each cDNA will yield 50–100 copies of biotin-
labeles cRNA; (4) cRNA was incubated at 94° in fragmen-
tation buffer to produce cRNA fragments of length 35
to 200 nucleotides; (b) Fragmented cRNA was hybridized
to the GeneChip Mouse Genome 430A 2.0 (c) scanned
in laser scanner and (d) data analysis performed. Brains
were dissected and hippocampi frozen on dry ice. The
Affymetrix GeneChip Mouse Genome 430 2.0(c) array
was chosen because at the time of the experiment, it pro-
vided the most comprehensive coverage of the mouse
genome. These high-density arrays containmultiple probe
pairs per probe set, providing several independent mea-
surements for every transcript. The array contains 45101
probe sets that measure the expression level of more
than 39,000 transcripts and variants, covering in excess of
19,000 well-characterized mouse genes.
Statistical analysis
Mean probe set intensities for 16 mice (eight of strain
C57BL/6J and eight of strain BALB/cJ) from Affymetrix
MOE 430 arrays were normalized and summarized using
RobustMultichip Average (RMA)method [46]. Probe sets
that were systematically absent (based on the MAS 5.0
detection present/absent call) across all the arrays were
removed leaving 22,690 probe sets [47]. Prior to analy-
sis, a plot of ordered probe set intensities was produced
to establish a suitable threshold above which intensities
could be considered true signals. The threshold chosen
was a mean probe set intensity of 250 that resulted in the
inclusion of 8627 measurements.
Principal Component Analysis/Partial Least Squares
(PCA/PLS)
Prior to PCA, probe-sets were further processed by using
mean-centering and Pareto scaling. Pareto scaling uses the
square root of the standard deviation as the scaling factor.
This method was chosen because it has two advantages
compared to traditional methods such as autoscaling.
First, large fold changes are penalizedmore than small fold
changes. Second the data does not become dimensionless
as with other scaling methods [48]. Principal component
Analysis (PCA) was performed on the data using pro-
cessed probe sets as X -variables. Two new Y-variables
were added to the data encoding: one pertaining to strain
(BALB/cJ or C57BL/6J) and one to the stress treatment
(UCMS or control). PCA was used to assess structure in
the mouse transcript data set and to summarize the data
set in an unbiased manner. This enables any potential
issues, such as unusual observations, to be investigated
prior to application of a supervised method. Additionally,
it allows us to ascertain if UCMS effects are visible at the
genomic level. We then conducted Partial Least Square
(PLS) analysis implemented in the SIMCA-P environment
(http://www.umetrics.com).
General Linear Models (GLM)
Main effects and interaction effects relating to strain,
sex and stress differences were investigated using general
linear models implement in R (http://cran.r-project.org)
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considering strain, sex and stress as fixed effects and
untransformed probe set summaries as dependent vari-
ables. In order to identify probe sets that could be
involved with the stress-sensitive phenotype of BALB/cJ
mice we further performed a correlational analysis in R.
Unstressed BALB/cJ animals were coded as group 1 and
all remaining animals as group 0. We calculated Pearson’s
correlation coefficient (R) between the two groups for
each probe set. Highly correlated probe sets, using a |R| >
0.8 cut-off, were selected and carried forward for pathway
analysis using Ingenuity Pathway Analysis (IPA) software
(Ingenuity Systems, Inc, Redwood City, California, USA,
http://www.ingenuity.com). IPA has been extensively used
to obtain networks revealing the molecular association
between the genes presented. Each network revealed by
IPA is scored according to the fit of significant genes in
each dataset using the Fisher exact test.
Weighted Gene Coexpression Network Analysis (WGCNA)
on BALB/cJ and C57BL/6J
WGCNA is designed to identify correlated gene mod-
ules, relate them to one another and associate them with
experimental factors [49]. WGCNA assigns a connec-
tion weight between pairs of genes within the network
based on biologically motivated criteria [50]. The identifi-
cation of relevant modules is achieved by the application
of soft threshold to correlations between pairs of genes
within a given network. The advantage of this method is
that it offers an unsupervised hypothesis-free network-
based gene screening to select probe sets associated with
a trait that makes it particularly suitable for multifactorial
mRNA studies. Prior to module detection, we conducted
a sample-clustering to check for the presence of out-
liers. No outliers were detected and we proceeded with
the optimisation of the soft-threshold values. Unassigned
co-expression networks were constructed using the block-
wiseModule function in the WGCNA package for R [51].
The function first computes a pairwise correlation matrix
for each set of genes and then calculates an adjacency
matrix by raising the matrix to a soft-threshold power.
Decision of the threshold power has been determined
using a scale-free topology criterion. Based on the scale
of independence we selected a threshold of 5. Probe sets
belonging to genemodules associated with stress response
were uploaded on the ingenuity pathway analysis software
to gain further insight into pathways that may be relevant
to stress response.
Cross-validation andWGCNAMeta-Analysis with GENDEP
study
Lastly, we looked for consensus modules between the
BALB/cJ and C57BL/6J study and an independent mouse
study from the GENDEP project using Weighted Gene
Coexpression Network Analysis in a Metanalysis design
(43,44). Comparison of coexpression analysis between
two independent studies may provide additional insight
into stress-related mechanisms. Briefly, data from 144
Affymetrix MOE 430 v2 mouse whole-genome microaar-
rays was normalized and summarized into probe sets
by Robust Multichip Average (RMA) method (37). Addi-
tional information on the GENDEP mRNA data prepro-
cessing can be found elsewhere [52]. Probsets from the
two versions of the same family of Affymetrix arrays,
430 MOE and 430MOE V2 respectively used in the two
studies, were matched using scripts written in Python
(https://www.python.org/). We first compared average
gene-expression and overall connectivity between the two
data sets and these showed high correlation, suggesting
similarity across the two datasets (Additional file 1: Figure
S1). We then conducted WGCNA adjusting power func-
tions parameters to create topological overlap (TO) as
described previously for each of the two studies sepa-
rately. Modules relating to stress factors where obtained
by hierarchical clustering. We then assessed the extent to
which modules in the BALB/cJ C57BL/6J study were pre-
served in the GENDEP study. The module labels from
the BALB/cJ/C57BL/6J study grouped in the GENDEP
dataset revealed good module preservation (Additional
file 2: Figure S2). This was tested using z-scores with the
modulePreservation function in theWGCNA package for
R, where |Z| > 10 represents high preservation. Lastly,
we compared the two gene-networks for consensus mod-
ules to uncover transcriptional similarities across the two
studies [53].
Results
PCA/PLS
Principal Component Analysis (PCA) was first used
to assess the structure in the mouse mRNA data set
(Figure 1). A total of four principal components were fit-
ted to the data set with a total variance explained (R2) of
0.67 and a cumulative predictive ability (Q2[cum]) of 0.24.
Plotting the scores reveals that the first unrotated princi-
pal component of variance can be interpreted as mouse
strain: there is a wide separation between C57BL/6J (tri-
angles) and BALB/cJ (circles) Figure 2. This is expected
as there are numerous known genetically-driven strain
differences. More interestingly, there is a clear separa-
tion of samples by treatment in the second component
(t[2]). This clearly highlights the stress-sensitivity of the
BALB/cJ strain. Examination of the loadings enables the
interpretation of which probe sets are contributing most
to the selected components. The probe sets represented
by points at the extreme left and right side of the load-
ings plot will tend to have greater values in the BALB/cJ
and C57BL/6J strain animals, respectively. The probe sets
represented by points at the extreme upper and lower
points of the loadings plot tend to have greater values
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Figure 1 Principal components analysis. Plotting the scores
following Pareto scaling shows that the first unrotated principal
component of variance can be interpreted as mouse strain. There is a
wide separation between C57BL/6J (triangles) and BALB/cJ (circles)
but this is expected as different strains reflect a different genetic
panel. A compelling result is the separation of samples by treatment
in the second component. There are striking differences between the
two strains in response to UCMS at this is clearly visible at the
genomic level. Additionally, the results show that the direction of the
UCMS effect is in opposing direction in C57BL/6J and BALB/6.
in the control and UCMS treated animals, respectively.
We then conducted PLS analysis on the same sample. A
PLS model was fitted to the mouse transcript data set
with four components, of which the first two captured
information relating directly to the strains and treatments.
The variance explained by the first two PLS components
in the X and Y data blocks were 0.44 and 0.90, respec-
tively. The Q2[cum] for the two model components was
0.75. Figure 2 shows plots of the scores and weights for
the two PLS components, coloured according to the strain
and treatment data (Additional file 3: Figure S3).
As was seen in the PCA scores plot, there is strong sep-
aration between the samples derived from the different
strains in the first components scores (t[1]) and between
the different treatments in the second components scores
(t[2]) (Figure 2A). Interpretation of the scores plot can be
made through inspection of the weights plot (Figure 2B).
PLS coefficients were used to determine the relevance of
the probe set intensities to the strain and treatment differ-
ences. An ordered plot of the coefficients for the first and
second components was used to determine thresholds for
selecting a probe set as relevant or not. Thresholds were
chosen as absolute coefficient values exceeding 5E-05 for
the strain and treatment y-variables in the first and sec-
ond PLS components, respectively. In each case, the sign
associated with the coefficients was interpreted as positive
values meaning the probe intensities tended to be higher
in C57BL/6J strain and mice exposed to the UCMS proto-
col, whilst negative values meant that the probe intensities
tended to be higher in BALB/cJ strain and control treated
mice.
We then explored the number of main effects and inter-
actions as part of a 2 × 2 ANOVA implemented in R. A
summary of probe sets uncovered at a p-value of 0.05,
False Discovery Rate and using Bonferroni correction is
provided in Table 1. When exploring main effect of stress,
two probe sets survived Bonferroni correction while 5
t[1] 
t[2
] 
p[
2]
 
p[1] 
A B
Figure 2 Scores and loading plots. PCA scores and loadings plots for the first two components of a model fitted to the mouse transcript data set.
Figure A shows scores plot with the observations color coded according the legend. Figure B shows the loadings plot of variables.
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Table 1 The results from a 2X2 ANOVA for each of the
22690 probesets on the array gives the following numbers
of candidates at the 0.05 cut off levels
Nominal FDR Bonferrorni
Environment 3163 22 2
Strain 6435 4742 555
Interaction 4274 626 5
probe sets in the stress X strain interaction analysis sur-
vived the same correction method. The differences by
treatment and the interaction, even at the Bonferroni
level shows that the UCMS stress protocol causes a suf-
ficiently strong biological insult in the stress-responsive
BALB/cJ. Probe sets were subsequently annotated with
Panther (www.panther.com); a summary of the top inter-
actions and UCMSmain effect hits at Bonferroni adjusted
level of significance is found in Table 2.
In order to cast a wider net, the 626 interaction
hits at q(FDR) =0.05 were uploaded to the Ingenuity
Pathway Analysis software. IPA revealed a group of 11
behaviourally interesting genes (Table 3). Of particular
interest are the three probesets that are high in the BALB-
UCMS group and essentially constant in the other groups
(Creb 1452529_a_at, Crem 1418322__at, Homer1
1425671_ at), which could be involved with the stress-
sensitive phenotype of BALB/cJ mice. To look for tran-
scripts following this pattern, we created two groups:
BALB-UCMS group as group one and the remaining ani-
mals as group two and calculated pearson’s R for this
variable with each probe set. The three probe sets men-
tioned above show correlations of 0.85, 0.82, and 0.92
respectively. At the stringent cut-off of |R| > 0.8, nominal
Table 2 The table shows the probe sets and corresponding
gene name uncovered from the ANOVA analysis
Top interaction hits
Probe set Gene name Description
1420093_s_at Hnrpdl heterogeneous nuclear
ribonucleoprotein D-like
1424891_a_at Zw10 ZW10 homolog (Drosophila),
centromere/kinetochore protein
1448609_at Tst thiosulfate sulfurtransferase,
mitochondrial
1449039_a_at Hnrpdl heterogeneous nuclear
ribonucleoprotein D-like
1450779_at Fabp7 fatty acid binding protein 7, brain
Top UCMS hits
1433439_at Cpne1 copine I
1448609_at Tst thiosulfate sulfurtransferase,
mitochondrial
All the probes sets listed survived Bonferroni correction for the number of
multiple non-independent testing.
p-value of 2e-5 and q-value < 0.026, we obtain 119 probe
sets. Probe sets were uploaded to the Ingenuity Pathway
Analysis software. IPA returned a gene network com-
prising 23 reference molecules with a score > 40. 15
genes belonging to this network were positively correlated
with BALB/cJ while 8 were negatively correlated. Nodes
in colour are on the |R| > 0.8 list, red are positively
correlated (ie BALB/cJ high) and green are negatively cor-
related. The pathway returned is of particular interest as
it is centred on the Nfkb complex (Figure 3). Nuclear fac-
tor Nfkb , is relevant to the depression in two ways. First it
has been shown to modulate glucocorticoid receptor sig-
nalling and thereby regulating CRH and proinflammatory
cytokins release. This is congruent with the inflammation
hypothesis of MDD. Second it plays a role in neuronal cell
growth, survival and synaptic plasticity, which makes it
relevant to the neurogenesis hypothesis of MDD [38].
Weighted gene co-expression network analysis
WGCNA was used to explore the functional organization
of the transcriptome in response to UCMS by construct-
ing a weighted gene coexpression network. WGCNA uses
the topological overlap (TO) to measure the coexpression
profile of genes pairs and neighbouring genes across the
network to uncover patterns of coexpression across the
transciptome. A total of 31 gene modules with at least
100 genes per modules were returned based on hierar-
chical clustering. Gene modules were then subsequently
related to the stress and strain factors. Four gene modules
in each condition were nominally associated with the two
experimental factors (stress and strain). Several modules
are significantly associated with strain effects but these are
expected as strain differences reflect a different genetic
background. One module showed a significant correla-
tion with stress and survives Bonferroni correction for the
number of modules tested R = 0.64, p = 0.007. This
module contains a total of 858 coordinately expressed
probe sets potentially involved in stress response mecha-
nism. These are subsequently uploaded to the Ingenuity
Pathway Analysis database. The results from IPA reveal
a significant stress-related gene network centred on the
Creb1 gene hub (Figure 4). The Creb1 gene has long been
nominated as potential convergent target for a wide-range
of antidepressant drugs and several animal studies have
reported an association between Creb1 and depressive-
related phenotypes [54].
Cross validation usingWGCNAmeta-analysis
As there is generally extensive variability across microar-
ray studies, it is important to cross-validate results
in an independent dataset. We have chosen a paral-
lel investigation from the GENDEP mouse arm that
used similar UCMS stress regime across 4 inbred mouse
strains. We used Weighted Gene CoExpression Network
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Table 3 The 626 interaction hits from the ANOVAmodel using strain and stress as main effects, at the c threshold of
q= 0.05 were uploaded on the Ingenuity Pathway Analysis database
Symbol Entrez gene name Affymetrix Location Type
Creb1 cAMP responsive element binding protein 1 1452529_a_at Nucleus transcription regulator
Crem cAMP responsive element modulator 1418322_at Nucleus transcription regulator
Fyn FYN oncogene related to SRC, FGR, YES 1448765_at Plasma Membrane kinase
Grik1 glutamate receptor, ionotropic, kainate 1 1427676_a_at Plasma Membrane ion channel
Homer1 homer homolog 1 (Drosophila) 1425671_at Plasma Membrane other
Htr1a 5-hydroxytryptamine (serotonin) receptor 1A 1450219_at Plasma Membrane G-protein coupled receptor
Il1b interleukin 1, beta 1449399_a_at Extracellular Space cytokine
Ncam1 neural cell adhesion molecule 1 1421966_at Plasma Membrane other
Npy neuropeptide Y 1419127_at Extracellular Space other
Ptpra protein tyrosine phosphatase, receptor type, A 1425340_a_at Plasma Membrane phosphatase
Vldlr very low density lipoprotein receptor 1417900_a_at Plasma Membrane transporter
IPA revealed a group of 11 associated genes associated with a stress response phenotype, several of which have been previously associated with depression and
depression-related phenotypes.
Analysis to compare two networks as described by Miller
et al. [53,55]. We measured the correlation between each
gene and Module Membership using kME values. This
resulted in 17 gene-modules being significantly corre-
lated across the two studies. We then determined which
genes are hubs across both networks by selecting genes
within each module correlating with stress response with
the highest kME values. A total of 170 probe-sets were
uncovered by this analysis and results were uploaded
on IPA Software. Out of 170 probe sets uploaded, 169
were found on the Ingenuity Pathway Analysis reference
database. The results returned a gene network centred on
the UBC, (Ubiquitin C) hub with a compelling score of 82
and consisting of 35 reference molecules (Figure 5). The
gene-network uncovered is functionally plausible and the
association between Ubc and stress response, well docu-
mented. The results from the Consensus modules across
the two experiments may help to point at putative mech-
anisms with higher probability of being involved in stress
response.
Discussion
This study investigated gene expression differences in the
context of a GxE model using two contrasting mouse
strains, BALB/cJ, a highly stress-reactive, anxious and
emotive strain with low basal locomotor activity and
C57BL/6, which is considered a less emotive and anx-
ious strain [56-59]. Additionally, C57BL/6Jmice have been
shown to produce twice the amount of serotonin in the
forebrain compared to BALB/cJ mice [60]. BALB/cJ mice
are known to exhibit depressive-related behaviours when
subjected to selected stress paradigms and offer much
promise for the study of stress response and as model
of depression and antidepressant treatment response in
humans.
One of the more compelling findings from our study is
the ability to separate groups by stress as well as strain,
simply through Principal Component Analysis. The sep-
aration by stress at the genomic level clearly points at
a sparsely distributed gene expression signal, sufficiently
pervasive to be clearly detected by PCA. Additionally,
the directionality of the effect seems to be in the oppo-
site direction when compared to C57BL/6J. This high-
lights the stress-sensitivity of the BALB/cJ mice and can
be used to identify gene and gene networks differen-
tially regulated in response to a chronic environmental
stressor. To gain further understanding into mechanisms
underpinning this effect, we used a correlational design
to uncover genes with higher prior probability of associ-
ation to stress response. Pathway analysis on the genes
that most highly correlate with genomic stress differences
belonged to a network centered on the Nfkb (nuclear
factor kappa B) gene complex, which plays an impor-
tant role in the regulation of oxidative stress-induced cell
activation.
The Nfkb gene complex can be stimulated through
environmental stressors and is considered a prototypi-
cal proinflammatory signalling pathway. This pathway has
been extensively associated with depressive related disor-
ders and is consistent with the inflammation hypothesis
of MDD. Nfkb is activated by proinflammatory cytokines
including interleukin 1 (IL-1) and tumor necrosis factor
(TNFα). Moreover, this gene complex has been shown
to play a role the expression of other proinflammatory
genes, cytokines, chemokines, and adhesion molecules
and plays an important role in modulating proinflamma-
tory cytokine production, leukocyte recruitment, and cell
survival [61].
We further explored the correlational patterns among
genes across microarray samples using Weighted Gene
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Figure 3 IPA Network. 119 unique probe sets were obtained through correlational analysis by coding UCMS BALB/cJ animals as group one and all
other animals as group 2 at the stringent |R| > 0.8 cut-off level. The results were uploaded on Ingenuity Pathway Analysis and a significant network
centred on the Nfkb gene hub was returned. The Nfkb has been associated with proinflammatory cytokines, such as IL-1beta which have been
implicated in the cellular and behavioral effects of stress response and in mood disorders. Regulation of Nfkb has further been suggested to
modulate hippocampal neurogenesis. Nodes on the diagram color coded represent reference molecules, with red indicating a positive correlation
value and green indicating a negative correlation value.
Coexpression Network Analysis WGCNA. WGCNA has
proven successful as an unsupervised method to identify
clusters of highly coexpressed genes and relating them
to external traits. Network pathway analysis conducted
on modules of coexpressed genes significantly associated
with stress response, returned a network centered on
the Creb1 gene complex. The transcription factor cAMP
response element-binding protein Creb1 is of particu-
lar interest and has been extensively implicated in both
the pathophysiology of MDD as well as in antidepressant
treatment response.
Creb1 is a transcription factor that regulates a num-
ber of different cellular responses including cell prolif-
eration, cell survival and plasticity and differentiation.
Indeed several studies have shown that administration of
cAMP breakdown inhibitors increases adult hippocam-
pal neurogenesis in mice. Conversely hippocampal cell
proliferation is decreased in transgenic mice that express
a dominant negative mutant of Creb1 in the hippocam-
pus [62]. Administration of antidepressant treatment has
been shown to increase CREB hippocampal neurogenesis
whilst reversing the negative effects of stress on this brain
region.
Additionally, Creb1 is induced by a range of factors
including inflammatory signals. Indeed there is grow-
ing literature suggesting that phosphorylated Creb1 may
directly inhibit Nfkb through mechanisms that include
blocking the binding of CREB proteins to the Nfkb com-
plex, increased production of IL-10 and generation of
Tregs [63]. The results from both the correlational and
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Figure 4 IPA from WGCNA results. Results from Weighted Gene Coexpression Network Analysis revaled 858 coordinatly expressed probes
associated with stress factors. The results were uploaded on the Ingenuity database and a signficant network, centred on the Creb1 gene hub was
returned. The Creb gene has extensively been associated with depression-related phenotypes as well as antidepressant treatment response.
coexpression analysis converge towards gene and gene
networks implicated in inflammatory signals. Indeed a
previous association between the same two mouse strain
and peripheral cytokins has been reported by Palumbo
et al., [64]. Their results suggest that stress induces a Th2
response in BALB/cJ and a Th1 response in C57BL/6J
mice. Dysregulation in cytokins have been systematically
implicated in human pathologies including major depres-
sive disorders and autoimmune diseases [65,66].
In order to gain additional insight into genes and
gene networks implicated in stress-response we per-
formed a WGCNA meta analysis with a parallel animal
model from the GENDEP project that utilises four inbred
mouse strains and the same stress paradigm (UCMS)
Intuitively, we hypothesised that there would be conver-
gence of stress-dependent gene modules that may provide
additional clues on molecules related to stress effects.
The analysis revealed good concordance across the stud-
ies. Pathway analysis on convergent genes across both
studies associated with stress revealed a highly signif-
icant network centred on the Ubiquitin-C (Ubc) gene
hub.
Ubiquitin-dependent protein degradation is essential
for cells to survive a wide-range of environmental stresses.
Perturbations in UBC levels could affect cell-survival
DNA repair, and regulation of other cell signaling path-
ways. Ubiquitin can bind to target proteins via an isopep-
tide bond via different Lys residues of the ubiquitin
(polyubiquitin chains). When conjugated with target
proteins, polyubiquitin chains serve different functions
depending on the Lys residue of the linked ubiquitin.
Lys-33-linked and Lys-63-linked ubiquitin plays a role in
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Figure 5 IPA from WGCNA Meta analysis results with the GENDEP project. In order to cross-validate the significant module from the WGCNA
analysis and gain additional insight into molecular mechanism associated with stress, related phenotypes, the results from convergent
gene-modules associated with stress response across the two, independent studies obtained with WGCNAmeta-analysis were uploaded on IPA. IPA
returned a highly scoring gene network clearly centered on the Ubiquitun-C (UBC) gene. Ubiquitin-C has been previously associated with mood
disorders and it is also known to be a stress-inducible protein.
kinase modification and signalling processes and leads to
activation of the transcription factor Nfkb. Several studies
of the Nfkb pathway have shown a role for ubiquitination
in addition to its well-known role in targeting protein
degradation. Ubiquitin has been associated with differ-
ent stages in the Nfkb pathway including, degradation
of the Nfkb, processing of Nfkb precursors inhibitor Ikb,
and activation of the Ikb kinase (IKK) via mechanisms
that are independent from those that regulate degrada-
tion [67-70]. Moreover several animal studies suggest that
the CREB repressor substrate is a target for degradation
by the ubiquitin-proteasome pathway [71,72]. Taken in
unison, the gene pathways identified across each of the
analyses converge towards mechanisms involving inflam-
mation. It has been suggested that the inflammatory
response is contained within the stress response as the
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same pathways are used. Changes in one system can
therefore lead to alternations in the other. Regarding the
lack of interaction with strain, this suggests that while
inflammation is a risk factor for MDD, other interac-
tions are critical for the development of depressive-like
symptoms. We have found a similar outcome with neu-
rogenesis, where broad decrease was found across strains
but did not correlate with the behavioral outcomes we
observed.
An interesting gene affected by UCMS exposure in our
study is the Il1b gene. Il1b, a pro-inflammatory cytokine,
has been shown to mediate the antineurogenic effects of
UCMS through activation of the Nfkb pathway. Inhibit-
ing this pathway pharmacologically or blocking Il1b sig-
nalling using receptor knockout mice, normalised sucrose
preference, a measure of anhedonia as well as other
depression and anxiety related behaviours. Studies have
shown that this gene plays a role in regularising the
proliferation of neural stem-like cells in UCMS exposed
mice, highlighting the importance of Il1b - Nfkb sig-
nalling in chronic stress paradigms [73,74]. Our findings
support the above studies as well as underline the gen-
eral role of neuroinflammation in stress disorders and
depression.
A further, functionally plausible gene uncovered by our
study is the Npy gene. This gene has been previously
associated with stress and emotional behavior in humans
and animals [75]. Interestingly, Npy gene is often men-
tioned in studies on stress resilience, which is attract-
ing increasing attention in studies on depression and
PTSD. Resilience is defined as the capacity of an individ-
ual to avoid negative social, psychological, and biologi-
cal consequences of extreme stress that would otherwise
compromise their psychological or physical well-being.
Resilience can be passive, i.e. the absence of key molec-
ular abnormalities which occur in susceptible individu-
als, and/or active, i.e. novel molecular adaptations which
occur uniquely in resilient individuals to help promote
normal behavioural function. Npy gene is viewed as part
of the latter and, although its precise role in stress cop-
ing strategies and depression needs further study, it has
been suggested that the Npy gene is generally protective
[76].
Lastly, we explored genes involved in the strain-stress
interaction. Only 5 genes survived Bonferroni correction
for multiple, non-independent, tests. However, none of
these genes have known association with stress response.
Moreover, the molecular substrate underpinning stress-
response may be highly polygenic and may not depend on
single genes of high penetrance.
The study was successful in highlighting genes and
genes network that may be associated with stress
response. As hypothesised, BALB/cJ animals showed
genomic alterations in response to environmental
stressors. The findings presented may be used to inform
future human studies on Major Depressive Disorder
where accurate history on the onset of stressful life events
and access to disease relevant brain tissues cannot be col-
lected. Indeed previous studies have shown that BALB/cJ
mice responded to chronic fluoxetine administration fol-
lowing a stress regime, compared with the non-anxious
C57BL/6J where the same drug had little effect. This is
consistent with equivalent observation in humans, where
antidepressants will induce a more potent effect in those
with a pre-existing mood imbalance and little effect in
individuals who are known to be well. Indeed the envi-
ronmental stressor plays against a genetic panel that
may predispose and individual to develop stress related
disorder at some stage in life.
Although we have provided evidence for a role of the
genes and gene pathways involved in stress response,
the study presents a number of limitations. First, it is
important to recognise the drawbacks of animal mod-
els within the context of human-related disorders. Whilst
there are overlapping behaviours and traits attributable
to mice and humans in response to common precipi-
tants, there is still an innate inconsistency comparing
two different species: animal cannot be considered minia-
ture human beings. Second, we used gene expression
profiles from two different studies. While this allowed
us to integrate and cross-validate results in indepen-
dent samples, this means our analyses were subject to
multiple testing. We did use statistically stringent cor-
rection thresholds but an inflation of false positives
remains possible. Third, changes in gene expression may
also be indicative of exposure to physiological changes
induced by UCMS rather than the development of
anhedonia or other features of depression-like pheno-
types.
Finally, there have been concerns that the UCMS
paradigm is difficult to replicate consistently across stud-
ies, and that combining data from two such studies,
as has been done here, should be done with caution
[77]. However, a recent literature review of over 60
research groups, highlighted that UCMS can induce
antidepressant reversible, depressive-like behaviours, in
rodents under appropriate conditions [78]. The authors
did, though, describe a genuine occasional phenomenon
wherein UCMS produced significant, but opposite,
effects.
Conclusion
In conclusion, an adverse environment produces stress-
related differences at a genomic level, more prevalent in
certain mouse strains. These differences involve several
candidate genes and gene networks that favour the contri-
bution of neurogenesis and inflammation in the pathology
of Major Depressive Disorder.
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Additional files
Additional file 1: Figure S1. Graphs showing the correlation scores of
average gene expression and overall connectivity between the two data
sets. The plots show significant correlation values which are positive in all
cases suggesting that the two datasets are comparable. Miller et al., report
that data for Connectivity is traditionally less correlated than for Expression
but all instances show a positive and significant correlation.
Additional file 2: Figure S2. The module labels in the BALB/cJ - C57BL/6J
study still group in the GENDEP dataset showing good module
preservation.
Additional file 3: Figure S3. PLS scores and weights. Figure A, shows
scores plot with the observations coloured according to the key below the
plot. Figure B shows weights plot for the variables. As was seen in the PCA
scores plot, there is strong separation between the samples derived from
the different strains in the first components scores (t[1]) and between the
different treatments in the second components scores (t[2]).
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